Fiona Marra Selected Research

Fiona Marra Research Topics

5	Infections 12/2022 - 01/2019
5	Fibrosis (Cirrhosis) 12/2022 - 01/2020
5	COVID-19 12/2022 - 12/2020
3	Chronic Hepatitis C 12/2021 - 01/2019
3	Hepatitis C 01/2020 - 03/2016
1	Hemorrhage 12/2022
1	Atrial Fibrillation 12/2022
1	Thrombosis (Thrombus) 12/2022
1	Peptic Ulcer (Peptic Ulcers) 01/2019
1	Gastroesophageal Reflux (GERD) 01/2019
1	Mental Disorders (Mental Disorder) 01/2019

7	Antiviral Agents (Antivirals)IBA 12/2022 - 03/2016
5	glecaprevir and pibrentasvirIBA 12/2021 - 01/2019
3	Ritonavir (Norvir)FDA Link 01/2022 - 12/2020
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 03/2021 - 12/2020
2	Lopinavir FDA Link 03/2021 - 12/2020
1	AnticoagulantsIBA 12/2022
1	nirmatrelvir and ritonavir drug combinationIBA 12/2022
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 12/2022
1	Oxygen (Dioxygen)IBA 12/2022
1	Warfarin (Coumadin)FDA LinkGeneric 12/2022
1	Fluvoxamine (Luvox)FDA LinkGeneric 01/2022
1	sarilumabIBA 03/2021
1	remdesivirIBA 03/2021
1	favipiravirIBA 03/2021
1	tocilizumab (atlizumab)FDA Link 03/2021
1	Atazanavir Sulfate (Reyataz)FDA Link 03/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 03/2021
1	Ribavirin (Virazole)FDA LinkGeneric 03/2021
1	Interferon-betaIBA 03/2021
1	Azithromycin (Zithromax)FDA LinkGeneric 03/2021
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 03/2021
1	AmberIBA 12/2020
1	Chloroquine (Aralen)FDA LinkGeneric 12/2020
1	velpatasvirIBA 01/2020
1	SofosbuvirIBA 01/2020
1	paritaprevirIBA 01/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2019
1	Antipsychotic Agents (Antipsychotics)IBA 01/2019
1	ombitasvirIBA 01/2019

4	Therapeutics 12/2022 - 01/2020
1	Duration of Therapy 03/2021
1	Investigational Therapies (Experimental Therapy) 12/2020